Schedule 13D ownership disclosure

CATALYST BIOSCIENCES INC

Security class unavailable · CUSIP: 14888D208

Event date: 2022-12-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-001641
Form type
SC 13D
Filer
GYRE THERAPEUTICS, INC.
CIK
CIK 1124105
Filed
Jan 05, 2023
Reporting period
Dec 26, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub